Glenmark set to join peers in 'Semaglutide' push

Glenmark set to join peers in 'Semaglutide' push

Glenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalates competition in a rapidly growing market. The Indian patent for semaglutide expires soon, allowing multiple local drugm…

Mumbai: Glenmark Pharmaceuticals is set to join Sun Pharmaceuticals, Dr Reddy's Laboratories, and Zydus Lifesciences among leading homegrown drugmakers to introduce cut-price versions of popular anti… [+2445 chars]

Related Posts

About FHMnews

What is FHMnews?

FHMnews is the result of a rebellion that transcended frustration. Look around you. As PK puts it, the people in this circle think one thing, say another, and do another. We shook up all three, confined within one circle, and decided to write as they think and speak. News, views, and everything beyond.

FHMnews is the country's first "new age" English news website. It's modern in its language, attitude, and news standards. It features selected news stories from the day, but with 360-degree coverage. It offers a complete report and analysis of each story, along with additional features like quizzes, polls, memes, and videos.

FHMnews Ltd.

E-43, Phase 8
Sahibzada Ajit Singh Nagar,
Punjab, 160071

Get In Touch With Us

© Copyright FHMnews
Glenmark set to join peers in 'Semaglutide' push - FHMnews